IDiyas

For the Inventor, By the Inventor

Belle Mead, NJ, United States of America

Karel F Bernady

USPTO Granted Patents = 27

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 101(Granted Patents)


Location History:

  • South Sommerville, NJ (US) (1979 - 1981)
  • Somerville, NJ (US) (1980 - 1981)
  • South Summerville, NJ (US) (1981)
  • Suffern, NY (US) (1976 - 1982)
  • Belle Mead, NJ (US) (1978 - 1986)

Company Filing History:

goldMedal27 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1976-1986

Loading Chart...
27 patents (USPTO):Explore Patents
1. 4610822 - Process for preparing 6-[D(-)-.alpha.-(4-C.sub.1 (1986-09-09),
2. 4439365 - Novel hydroxy substituted prostanoic acids, esters, congeners, (1984-03-27),
3. 4343949 - Novel 2-substituted-3,4-epoxycyclopentan-1-ones, (1982-08-10),
4. 4293704 - Novel 2-substituted-3,4-epoxycyclopentan-1-ones, (1981-10-06),
5. 4245121 - Prostenoic acids and esters (1981-01-13),
6. 4243817 - Prostenoic acids and esters (1981-01-06),
7. 4237316 - Novel 2-substituted-3,4-epoxycyclopentan-1-ones, (1980-12-02),
8. 4217308 - Process for preparing N-alkylethylenediamines (1980-08-12),
9. 4202988 - Prostenoic acids and esters (1980-05-13),
10. 4197407 - Prostenoic acids and esters (1980-04-08),
11. 4179574 - Novel 2-substituted-3,4-epoxycyclopentan-1-ones, (1979-12-18),
12. 4178456 - Prostenoic acids and esters (1979-12-11),
13. 4140715 - Process for preparing N-(1,1-dimethyl-3-oxobutyl)acrylamide from a (1979-02-20),
14. 4140714 - Process for preparing N-(1,1-dimethyl-3-oxobutyl)acrylamide from a (1979-02-20),
15. 4123456 - Novel 11-hydroxy-9-keto-5,6-cis-13,14-cis-prostadienoic acid derivatives (1978-10-31),

Title: Karel F. Bernady: A Pioneer in Pharmaceutical Innovations

Introduction

Karel F. Bernady, based in Belle Mead, NJ, is a prominent inventor recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 27 patents, Bernady has established himself as a leading figure in the development of innovative compounds and processes that have advanced medical treatments.

Latest Patents

Among his latest patents are two noteworthy innovations: a process for preparing 6-[D(-)-α-(4-C1 - alkyl-2,3-dioxo)]-piperazinocarbonylamino)phenylacetamid o]penicillanic acids and related pharmaceutically acceptable salts, and novel hydroxy substituted prostanoic acids. The latter includes certain 11-hydroxy and 11-deoxy-9-keto (or hydroxy)-prostanoic acid derivatives, which are potentially valuable as bronchodilators, anti-ulcer agents, or intermediates in further pharmaceutical development.

Career Highlights

Karel F. Bernady works at the American Cyanamid Company, a well-respected organization in the pharmaceutical industry. His career is marked by a commitment to innovation and a deep understanding of chemical processes that lead to effective medical solutions. His extensive patent portfolio underscores his importance in the advancement of pharmaceutical applications.

Collaborations

Throughout his career, Bernady has collaborated with esteemed co-inventors, including Martin J. Weiss and John F. Poletto. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and applicability of their innovations in the pharmaceutical domain.

Conclusion

Karel F. Bernady stands out as a significant contributor to the field of pharmaceuticals through his inventive spirit and collaborative efforts. His dedication to advancing healthcare solutions reflects a profound commitment to innovation and the betterment of human health. As he continues to develop groundbreaking processes and compounds, the impact of his work will undoubtedly resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…